PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
January 22, 2026Cancers1 citationsOpen Access

Oncological Outcomes and Genomic Features of Gastric-Type Endocervical Adenocarcinoma, the Most Aggressive and Common HPV-Independent Cervical Cancer

View Full Paper
MDMing DuZZZhen ZhengPLPeiyao Lu

Key Points

  • To summarize clinicopathological information and perform prognostic analysis of gastric-type endocervical adenocarcinoma.
  • Included 182 patients diagnosed with GEA from 2014 to 2025.
  • Sourced additional cases from online databases.
  • Analyzed clinical symptoms, staging, and survival outcomes.
  • 39.56% experienced vaginal bleeding and 35.16% reported watery discharge.
  • 64% of GEA cases were stage IIB–IV at diagnosis, with a 5-year survival rate of 41%.
  • 49.64% had lymphovascular space invasion, while 42.00% experienced lymph node metastasis.
  • Deep invasion depth and ovarian metastasis were linked to worse overall survival.

Abstract

Background/Objectives: In order to develop a comprehensive understanding of gastric-type endocervical adenocarcinoma (GEA), an increasingly prevalent HPV-independent cervical cancer, we summarized clinicopathological information and performed prognostic analysis. Methods: A total of 182 patients diagnosed with GEA at our center during the period 2014–2025 were included in this study. Nineteen GEA cases, 6 HPV-independent non-GEA cases, 59 HPV-associated usual endocervical adenocarcinoma cases, and 66 squamous cell carcinoma cases from online database were also included. Results: Vaginal bleeding (39.56%) and watery discharge (35.16%) were the most common symptoms. As many as 21.43% of patients had no specific complaints, and 80% of GEA showed no distinct mass through gynecological examination. A total of 64% of GEA were stage IIB–IV at diagnosis, with a 5-year survival of 41% versus 85% for stage I–IIA (p < 0.05). The rate of lymphovascular space invasion (LVSI), lymph node metastasis, and ovarian metastasis were 49.64%, 42.00%, and 29.29%, respectively. The 5-year survival and recurrence rates after primary therapy were 57% and 23%, respectively. For GEA treatment, surgery might be associated with improved overall survival for the population at stage III–IV. Survival analysis identified deep infiltration depth (≥2/3), a maximum diameter of the tumor (MDOT) of ≥3 cm, and ovary metastasis as potential indicators of worse OS and PFS for whole patients. Additionally, ovary metastasis indicated poor PFS and OS for stage I–II. Genomic information TP53 mutation, PTEN deletion and STK11 mutation might be the most prevalent genomic alterations. Conclusions: These findings indicated GEA as an aggressive cervical cancer, with high rate of lymph node metastasis, high recurrence rate and short 5-year survival. Ovary metastasis reflected advanced disease burden and surgery might be associated with improved survival in advanced stage. For genomic information, GEA showed genetic heterogeneity and a low level of genomic instability.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Du et al. (2026) studied this question.

synapsesocial.com/papers/6971bea8642b1836717e352bhttps://doi.org/10.3390/cancers18020320
Ask AI
Helpful
Bookmark
Share
View Full Paper